Skip to main content
Top
Literature
Metadata
Title
Reply to the Letter by M.S. Raghuraman Regarding “Perioperative Management of Diabetes Mellitus: Novel Approaches”
Authors
Nadine E. Palermo
Rajesh Garg
Publication date
01-10-2019
Publisher
Springer US
Keyword
Hypoglycemia
Published in
Current Diabetes Reports / Issue 10/2019
Print ISSN: 1534-4827
Electronic ISSN: 1539-0829
DOI
https://doi.org/10.1007/s11892-019-1227-1

Other articles of this Issue 10/2019

Current Diabetes Reports 10/2019 Go to the issue

Obesity (KM Gadde, Section Editor)

Predictive Mathematical Models of Weight Loss

Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)

Care of Children and Adolescents with Diabetes Mellitus and Hyperglycemia in the Inpatient Setting

Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors)

What Have Slow Progressors Taught Us About T1D—Mind the Gap!

Obesity (KM Gadde, Section Editor)

Medical Devices in Obesity Treatment

Hospital Management of Diabetes (A Wallia and JJ Seley, Section Editors)

Inpatient Management of T2DM and Hyperglycemia in Older Adults

Microvascular Complications—Retinopathy (DL Chao and G Yiu, Section Editors)

Surgical Innovations in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine